Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tilray Brands Inc (NQ: TLRY )

1.830 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 56,367
Open 1.830
Bid (Size) 1.820 (2)
Ask (Size) 1.830 (62)
Prev. Close 1.830
Today's Range 1.830 - 1.830
52wk Range 1.600 - 3.400
Shares Outstanding 730,289,573
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top Pot Picks: 3 Unstoppable Cannabis Stocks Set to Blaze Past Competition
These are the cannabis stocks to buy as they represent companies with good fundamentals and a robust growth outlook 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
A Comparative Analysis Of The 12 Largest Cannabis Companies Puts Green Thumb 1
This article compares the Gross Profit margin; Selling General and Administration expenses; adjusted Earnings Before Interest, Taxes, Depreciation and Amortization and Net Profit Margin as a % of a Net... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis

Performance

YTD
-17.57%
-17.57%
1 Month
+2.81%
+2.81%
3 Month
-9.41%
-9.41%
6 Month
-8.50%
-8.50%
1 Year
+3.39%
+3.39%

More News

Read More
Bearish Sentiment Across The Cannabis Space - Check Full Movers For July 10, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Get Ready to Elevate Your Cannabis Experience With Good Supply's Latest Signature Vape Innovations
From Tilray Brands, Inc.
Via GlobeNewswire
Will the U.S. Election Help Give Tilray Brands and Canopy Growth a Year-End Boost?
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Hold My Beer: Breweries Offer THC On Tap In Minnesota, What Investors Need To Know
Via Benzinga
90% Of Medical Marijuana Patients Over 50 Are Treating Chronic Pain And Arthritis, Finds New Tilray Study
Via Benzinga
Topics Cannabis
Exposures Cannabis
7 Pot Stock Pioneers Poised for High Returns
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Tilray Medical Announces Scientific Study on Medical Cannabis for Patients Over Age 50
From Tilray Brands, Inc.
Via GlobeNewswire
3 Cannabis Stocks Ready to Blaze as Regulations Ease
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - 2024 YTD Review
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Advocates Say GOP Using Marijuana Odor as Excuse to Preach Prohibition
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Budding Fortunes: 7 Cannabis Stocks With the Potential to Make You a Millionaire
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
3 Stocks Under $3 That Can Trade in Double Digits in 2025
Via InvestorPlace
Marijuana Stock Movers For July 4, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
7 Cannabis Stocks to Sell in July Before They Crash & Burn
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From July 3, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Decibel's Dominance In Pre-Rolls Tested By Market Shifts And 16% Revenue Drop: What Investors Need To Know
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Is What a Top Cannabis Executive Thinks Is Going to Happen in the Industry in the Next 10 to 15 Years
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
3 Low-Priced Stocks With 100%+ Upside Potential
Via InvestorPlace
420 with CNW — Florida Medical Cannabis Patients Surprised by Email Blast
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
12 Largest Cannabis Stocks Declined +11%, On Average, In June
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Will Biden's Shaky Debate Performance Affect Cannabis Reform? How A Trump Return Could Reshape Marijuana Policy
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Bearish Friday For Marijuana Stocks - Global Compliance, 1933 Industries Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Is Tilray's $2B Valuation Just The Beginning? Analyst Sees $10B Market Opportunity, Initiates Coverage
Via Benzinga
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.